
Smith and Sapphire Bio-Tech Limited
About Smith and Sapphire Bio-Tech Limited
Data last updated:
Smith and Sapphire Bio-Tech Limited is a public limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 03 February 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1995PLC065063.
The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹4 Cr. It is led by directors including Rohit Choudhary Kumar and Mahmud Kazi.
Its last annual general meeting (AGM) was held on 28 September 2011, and its latest financial statements are for the year ended 31 March 2011. The registered office is at C – 128/1 First Floor Mohammadpur Bhikaji Cama Place, New Delhi, Delhi, India – 110066.
As per MCA filings, the company has open charges of ₹1.84 Cr on record.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Smith and Sapphire Bio-Tech Limited's registered office is in New Delhi, Delhi.
- Registered AddressC – 128/1 First Floor Mohammadpur Bhikaji Cama Place, New Delhi, Delhi, India – 110066
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Smith and Sapphire Bio-Tech Limited
FY 2011 filings availableFinancial Statement Summary
| Metrics | FY 2010-11 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2010-11 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Smith and Sapphire Bio-Tech Limited, buy the company report.
Board of directors of Smith and Sapphire Bio-Tech Limited
Smith and Sapphire Bio-Tech has 3 current directors and 13 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rohit Choudhary Kumar | Director | 28 May 2016 | 10 Years 5 Months | Current |
| Mahmud Kazi | Director | 28 May 2016 | 10 Years 5 Months | Current |
| Dilip Kumar Pandey | Director | 28 May 2016 | 10 Years 5 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Aug 2013 | 10446008 | Oriental Bank of Commerce | ₹14.35 Lakh | Open | |
| 12 Dec 2012 | 10496310 | Oriental Bank of Commerce | ₹90 Lakh | Open | |
| 24 Oct 2009 | 10190078 | Punjab National Bank | ₹80 Lakh | Open |
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Smith and Sapphire Bio-Tech Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Smith and Sapphire Bio-Tech Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Smith and Sapphire Bio-Tech Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Smith and Sapphire Bio-Tech Limited has 16 board changes on record since 2011: 3 appointments and 13 cessations. The latest: Dilip Kumar Pandey was appointed as Director on 28 May 2016.
10 earlier events are in the company report.
Frequently asked questions
Smith and Sapphire Bio-Tech is an active public limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 03 February 1995 (31+ years old) and is registered under CIN U74899DL1995PLC065063.
Smith and Sapphire Bio-Tech has 3 current directors:
- Rohit Choudhary Kumar - Director
- Mahmud Kazi - Director
- Dilip Kumar Pandey - Director
The latest financial statements of Smith and Sapphire Bio-Tech on record with the MCA are for the year ended 31 March 2011. Its last annual general meeting was held on 28 September 2011. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Smith and Sapphire Bio-Tech is U74899DL1995PLC065063. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Smith and Sapphire Bio-Tech was incorporated on 03 February 1995, making it 31+ years old. It is registered with the Registrar of Companies, Delhi.
Dilip Kumar Pandey was appointed as Director on 28 May 2016. Mahmud Kazi was appointed as Director on 28 May 2016. Rajesh Kumar ceased to be Director on 28 May 2016. Smith and Sapphire Bio-Tech has 16 board changes on record in total.
The registered office of Smith and Sapphire Bio-Tech is at C – 1281 First Floor Mohammadpur Bhikaji Cama Place, New Delhi, Delhi, India – 110066.
Smith and Sapphire Bio-Tech operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Smith and Sapphire Bio-Tech has open charges of ₹1.84 Cr and no satisfied charges on record as per latest MCA filings.
The compliance status of Smith and Sapphire Bio-Tech is active non-compliant as of 28 September 2026. The company is actively filing with the Registrar of Companies.

